HES3 (hes family bHLH transcription factor 3) is a basic helix-loop-helix transcriptional repressor that functions as a key regulator of cell fate determination and stem cell biology 1. The protein contains bHLH, Orange, and Proline-rich domains along with a WRPW motif, and operates through the non-canonical STAT3-Ser/Hes3 signaling axis 12. HES3 plays critical roles in multiple tissues: it regulates neural stem cell growth and survival, with implications for neurodegenerative diseases and remyelination processes 3; controls pancreatic islet cell function by regulating Pdx1 and insulin expression, affecting cell growth and insulin release 4; and is expressed in ocular surface tissues where it associates with stem cell populations 5. Clinically, HES3 has significant disease relevance in cancer, where it promotes malignant phenotypes by upregulating cell cycle regulators like Cyclin D1, Cyclin D3, and MMP7 in lung cancer 6, and serves as a PAX3-FOXO1 target in rhabdomyosarcoma, inhibiting myogenic differentiation and correlating with poor prognosis 7. The protein's diverse expression pattern and regulatory functions across neural, endocrine, and cancer contexts highlight its importance as both a developmental regulator and potential therapeutic target 8.